Meribank Biotech Co., Ltd (TPEX:4724)
Taiwan
· Delayed Price · Currency is TWD 17.05
+0.05 (0.29%)
Jun 26, 2025, 11:57 AM CST
Meribank Biotech Market Cap
Meribank Biotech has a market cap or net worth of 1.50 billion as of June 25, 2025. Its market cap has decreased by -36.44% in one year.
Market Cap
1.50B
Enterprise Value
2.29B
Revenue
366.43M
Ranking
n/a
PE Ratio
n/a
Stock Price
17.05
Market Cap Chart
Since June 16, 2023, Meribank Biotech's market cap has decreased from 1.95B to 1.50B, a decrease of -23.15%. That is a compound annual growth rate of -12.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 24, 2025 | 1.47B | -40.36% |
| Dec 31, 2024 | 2.46B | 2.99% |
| Dec 29, 2023 | 2.39B | 22.90% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 190.00B |
| PharmaEssentia | 181.63B |
| Bora Pharmaceuticals Co., LTD. | 84.20B |
| Lotus Pharmaceutical | 57.58B |
| Oneness Biotech | 31.37B |
| Polaris Group | 29.05B |
| Center Laboratories | 27.35B |
| Lumosa Therapeutics | 25.66B |